Back Muscle Tendon Fasciitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of traditional Chinese and western medicine for back myofascitis; (2) Meet the TCM syndrome differentiation standard of cold and dampness obstruction syndrome, qi stagnation and blood stasis syndrome; (3) Acute phase of myofasciitis and acute phase of chronic pain, the number of onset is <30 days, the course of disease is not limited; (4) The attack site is located in the thoracic and dorsal region, that is, the line from the 7th cervical spine to the two sides of the acromion is taken as the upper boundary, and the line from the 12th thoracic spine and the lower edge of the 12th costal to the front of the 11th rib is the next area of the spine and the rear and the soft tissues on both sides; (5) Pain VAS score: 0 <VAS <7; (6) No gender limit, age between 18 and 65 years old; (7) Did not take analgesic drugs or received other analgesic treatment in the last 2 weeks; (8) Voluntary participation and the signing of the informed consent form; All the above can be included
Exclusion criteria
Exclusion criteria: (1) Acute torticollis, severe spinal stenosis or spinal deformities, thoracic vertebral dislocation, spondylolisthesis, tumors, tuberculosis, fractures, mandatory spondylitis, rheumatic diseases, and back pain caused by other diseases. (2) Patients with combined upper gastrointestinal ulcers, history of bleeding, ischemic heart disease or cerebrovascular disease (perioperative period of coronary artery bypass grafting, history of stroke or ischemic attack), renal dysfunction, disorders of coagulation mechanisms (including the use of anticoagulants), and other serious life-threatening primary diseases such as heart, brain, liver, kidney, endocrine, and blood systems, as well as mental illness. (3) Pregnant and lactating women. (4) There are any contraindications to moxibustion, such as scars or infections on the moxibustion site, or researchers believe that the moxibustion site may cause Individuals with systemic diseases who are currently not suitable for taking measures. (5) Clinical researchers believe that participants in clinical studies cannot cooperate with therapists. (6) Participants in other research projects. Any one of the above shall be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| McGill Pain Questionnaire Short-Form; | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-36; | — |
Countries
China
Contacts
Dongzhimen Hospital of Beijing University of Chinese Medicine